Annual Current Liabilities
$10.81 M
-$4.18 M-27.88%
31 December 2023
Summary:
SAB Biotherapeutics annual total current liabilities is currently $10.81 million, with the most recent change of -$4.18 million (-27.88%) on 31 December 2023. During the last 3 years, it has fallen by -$248.40 thousand (-2.25%). SABS annual current liabilities is now -59.13% below its all-time high of $26.46 million, reached on 31 December 2021.SABS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$8.82 M
+$1.26 M+16.74%
30 September 2024
Summary:
SAB Biotherapeutics quarterly total current liabilities is currently $8.82 million, with the most recent change of +$1.26 million (+16.74%) on 30 September 2024. Over the past year, it has dropped by -$394.70 thousand (-4.29%). SABS quarterly current liabilities is now -66.68% below its all-time high of $26.46 million, reached on 31 December 2021.SABS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SABS Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.9% | -4.3% |
| 3 y3 years | -2.3% | +2634.6% |
| 5 y5 years | - | - |
SABS Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -59.1% | at low | -66.7% | +2634.6% |
| 5 y | 5 years | -59.1% | +134.2% | -66.7% | +2634.6% |
| alltime | all time | -59.1% | +134.2% | -66.7% | +2634.6% |
SAB Biotherapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.82 M(+16.7%) |
| June 2024 | - | $7.55 M(-9.1%) |
| Mar 2024 | - | $8.30 M(-23.2%) |
| Dec 2023 | $10.81 M(-27.9%) | $10.81 M(+17.4%) |
| Sept 2023 | - | $9.21 M(-16.3%) |
| June 2023 | - | $11.01 M(-19.4%) |
| Mar 2023 | - | $13.67 M(-8.9%) |
| Dec 2022 | $14.99 M | $14.99 M(-12.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $17.10 M(+6.0%) |
| June 2022 | - | $16.14 M(-11.6%) |
| Mar 2022 | - | $18.26 M(-31.0%) |
| Dec 2021 | $26.46 M(+139.2%) | $26.46 M(+8105.7%) |
| Sept 2021 | - | $322.40 K(-96.8%) |
| June 2021 | - | $10.20 M(-7.8%) |
| Dec 2020 | $11.06 M(+139.5%) | $11.06 M |
| Dec 2019 | $4.62 M | - |
FAQ
- What is SAB Biotherapeutics annual total current liabilities?
- What is the all time high annual current liabilities for SAB Biotherapeutics?
- What is SAB Biotherapeutics annual current liabilities year-on-year change?
- What is SAB Biotherapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for SAB Biotherapeutics?
- What is SAB Biotherapeutics quarterly current liabilities year-on-year change?
What is SAB Biotherapeutics annual total current liabilities?
The current annual current liabilities of SABS is $10.81 M
What is the all time high annual current liabilities for SAB Biotherapeutics?
SAB Biotherapeutics all-time high annual total current liabilities is $26.46 M
What is SAB Biotherapeutics annual current liabilities year-on-year change?
Over the past year, SABS annual total current liabilities has changed by -$4.18 M (-27.88%)
What is SAB Biotherapeutics quarterly total current liabilities?
The current quarterly current liabilities of SABS is $8.82 M
What is the all time high quarterly current liabilities for SAB Biotherapeutics?
SAB Biotherapeutics all-time high quarterly total current liabilities is $26.46 M
What is SAB Biotherapeutics quarterly current liabilities year-on-year change?
Over the past year, SABS quarterly total current liabilities has changed by -$394.70 K (-4.29%)